(19)

(11)

EP 3 119 793 A1

(12)

(43) Date of publication: 25.01.2017 Bulletin 2017/04 (21) Application number: 15711122.0 (22) Date of filing: 17.03.2015

(51) International Patent Classification (IPC):  C07H 17/08(2006.01) A61P 31/04(2006.01) (86) International application number: PCT/EP2015/055531 (87) International publication number: WO 2015/140153 (24.09.2015 Gazette 2015/38)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: MA (30) Priority: 18.03.2014 US 201461954715 P 03.07.2014 US 201462020570 P (71) Applicant: Xellia Pharmaceuticals ApS 2300 Copenhagen S (DK)	(72) Inventor: KLUGE, Stefan 4125 Riehen (CH) (74) Representative: Onsagers AS  P.O. Box 1813 Vika 0123 Oslo 0123 Oslo (NO)